AMGN Amgen
$435.64 -0.72%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-0.72%
YTD
+33.10%
P/E
25.13
P/B
20.36
ROE
85.6%
Div yield
3.2%
Beta
0.49
Market cap
$236.0B
RSI (14)
41
Next earnings
Feb 1, 2027
Same sector · Health Care
Compare AMGN with NVO and JNJ →Follow AMGN in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$443.05
Close
$435.64
Day high
$445.49
Day low
$434.51
Volume
4.9M
Latest headlines
Viridian Therapeutics' Lumvoa Emerging as Rival to Amgen's Tepezza, BofA Securities Says
Yahoo Finance · Nov 19
Amgen (AMGN) Has Advanced MariTide Into Phase 3 Trials
Yahoo Finance · Nov 19
Should Biogen Stock Holders Look At Amgen Instead?
Yahoo Finance · Nov 19
iShares Biotechnology ETF (IBB) Buys $16.2 Million More Gilead on Nov. 16
Yahoo Finance · Nov 18
Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035
Yahoo Finance · Nov 17
What iShares Biotechnology ETF (IBB) Bought: Gilead Leads on Nov. 13
Yahoo Finance · Nov 17
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Nov 4, 2026 View → 8-K Nov 3, 2026 View → 8-K Oct 27, 2026 View → 10-Q Aug 5, 2026 View → 8-K Aug 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell AMGN. Try it in the Lab to size a position and see the risk.